The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration.

Although previous studies have demonstrated that hypoxia induces retinal ganglion cell (RGC) apoptosis and that transient retinal ischemia upregulates the expression of lysophosphatidic acid (LPA) receptors, it remains to be determined whether LPA(1) receptor mediates RGC degeneration during retinopathy of prematurity (ROP). By using an immortalized RGC line (RGC-5), primary neonatal RGC cultures, and oxygen-induced retinopathy (OIR) to model ROP, the authors explored whether LPA(1) receptor induces RGC degeneration and the potential mechanisms thereof.
OIR was induced by exposing rat pups to alternating cycles of hyperoxia/hypoxia from postnatal day (P) 0 to P14. RGC viability was evaluated by Fluorogold labeling. Effects of hyperoxia or hypoxia on LPA(1) expression were determined in the RGC-5 line by Western blot. Roles of hypoxia, LPA(1) receptor (with agonist, stearoyl-LPA; antagonist, THG1603; LPA(1) knock-down, shRNA-LPA(1)), and Rho kinase (with inhibitor Y-27632) in mediating RGC survival and neurite outgrowth were assessed by MTT assay and phase-contrast microscopy, respectively. Expression of GFP-LPA(1) in RGC-5 under hypoxia was examined by confocal microscopy.
OIR caused pronounced RGC loss in the retina. LPA(1) receptor was expressed by RGCs in retinal tissue, whereas oxygen stress induced its expression in RGC-5. Exposure to stearoyl-LPA or hypoxia substantially reduced the viability of RGCs; this was abrogated by THG1603 and shRNA-LPA(1). THG1603 and Y-27632 treatment also attenuated the adverse effects of hypoxia on RGC-5 neurite outgrowth, and their intravitreal administration prevented OIR-induced RGC loss. Interestingly, overexpression of LPA(1) increased RGC-5 susceptibility to hypoxia-induced cell loss.
Current data strongly support a critical role for LPA(1) receptor in mediating RGC degeneration during OIR.
AuthorsChun Yang, Josiane Lafleur, Bupe R Mwaikambo, Tang Zhu, Carmen Gagnon, Sylvain Chemtob, Adriana Di Polo, Pierre Hardy
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 50 Issue 3 Pg. 1290-8 (Mar 2009) ISSN: 1552-5783 [Electronic] United States
PMID18978343 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amides
  • Enzyme Inhibitors
  • Pyridines
  • Receptors, Lysophosphatidic Acid
  • Y 27632
  • Green Fluorescent Proteins
  • rho-Associated Kinases
  • Oxygen
  • Amides (pharmacology)
  • Animals
  • Animals, Newborn
  • Anoxia (metabolism)
  • Blotting, Western
  • Cell Culture Techniques
  • Cell Survival
  • Disease Models, Animal
  • Enzyme Inhibitors (pharmacology)
  • Green Fluorescent Proteins (genetics)
  • Humans
  • Infant, Newborn
  • Microscopy, Fluorescence
  • Oxidative Stress
  • Oxygen (toxicity)
  • Plasmids (genetics)
  • Pyridines (pharmacology)
  • Rats
  • Rats, Long-Evans
  • Receptors, Lysophosphatidic Acid (physiology)
  • Retinal Degeneration (metabolism)
  • Retinal Ganglion Cells (metabolism, pathology)
  • Retinopathy of Prematurity (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • rho-Associated Kinases (antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: